http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5951295-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
filingDate 1982-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67c068bb4ca35bba614276ca2031e5be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217a962a9ab73afd02e9ae029934e4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_068fe7273b66baa9df10cd17b15edab4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a59ecab49c58a5c32bff2dbbcd0a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b420039ef60c805fdba878b52c43ad2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7075e27f4f24c3e6a3a10817e3cab0da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86dd227f333b51502edb0c05aff9d866
publicationDate 1984-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5951295-A
titleOfInvention Phosphorus-containing peptide
abstract NEW MATERIAL:The compound of formula I [R 1 is H, lower alkyl, acyl, lower alkoxycarbonyl, etc.; R 2 is H, (substituted) lower alkyl, (substituted) aryl, etc.; R 3 is H, lower alkyl, aralkyl, acyl, or lower alkoxycarbonyl; R 4 is H or lower alkyl] and its salt. n EXAMPLE: N-( N-t-Butoxycarbonyl-L-isoleucyl-L-phenylalanyl-( R )-(-)-1-amino-2-(4- benzyloxyphenyl)ethylphosphonic acid diethyl ester hydrochloride. n USE: Antihypertension agent. n PROCESS: The compound of formula I can be prepared, e.g. by reacting the compound of formula II [Y is amino-protecting group; R 2 ' is (protected) R 2 ] with the compound of formula III (R 3 ' and R 4 ' are R 3 and R 4 except H), eliminating the amino-protecting group, reacting the product with the compound of formula IV(R 1 ' is R 1 except H), and if necessary, removing the protecting groups from the product. n COPYRIGHT: (C)1984,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015508405-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8987408-B2
priorityDate 1982-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5885896-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6534

Total number of triples: 33.